Bio-Techne (TECH) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Bio-Techne Releases Third Quarter Fiscal 2019 Results
April 30, 2019 6:30 AM EDTMINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2019.
Third Quarter FY2019 Snapshot
Third quarter organic growth of 14% (13% reported) with revenue of $184.9 million. GAAP EPS was $1.15 vs. $0.52 one year ago. Delivered adjusted earnings per share (EPS) of $1.21, consistent with the prior year despite foreign currency exchange headwinds negatively impacting results by $0.10 or 8% in the third quarter. Excellent commercial execution in all major regions, with North America, Europe, and China all achieving double digit organic... More


